4-甲氧基甲基苯基硼酸 | 279262-11-2

• 物质功能分类: 化学试剂 - 有机试剂 - 硼酸
• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: 4-甲氧基甲基苯基硼酸
• 中文别名: 4-(甲氧基甲基)苯硼酸；4-(甲氧基甲基)苯基硼酸
• 英文名称: (4-(methoxymethyl)phenyl)boronic acid
• 英文别名: 4-(Methoxymethyl)phenylboronic acid；[4-(methoxymethyl)phenyl]boronic acid
• CAS: 279262-11-2
• 化学式: C₈H₁₁BO₃
• 分子量: 165.985
• InChiKey: VTNVZXAYRMTKON-UHFFFAOYSA-N

物化性质

• 沸点：
  296.2±42.0 °C(Predicted)
• 密度：
  1.13±0.1 g/cm3(Predicted)
• 溶解度：
  溶于甲醇

计算性质

• 辛醇/水分配系数(LogP)：
  -0.49
• 重原子数：
  12
• 可旋转键数：
  3
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.25
• 拓扑面积：
  49.7
• 氢给体数：
  2
• 氢受体数：
  3

安全信息

• 危险等级：
  IRRITANT
• 危险品标志：
  Xi
• 海关编码：
  2931900090
• 危险性防范说明：
  P261,P305+P351+P338
• 危险性描述：
  H315,H319,H335
• 储存条件：
  室温

SDS

Material Safety Data Sheet

---

Section 1. Identification of the substance
4-Methoxymethylphenylboronic acid
Product Name:
Synonyms: 4-(Methoxymethyl)phenylboronic acid

---

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.
H315: Causes skin irritation
H319: Causes serious eye irritation
H335: May cause respiratory irritation
P261: Avoid breathing dust/fume/gas/mist/vapours/spray
Wear protective gloves/protective clothing/eye protection/face protection
P280:
P305+P351+P338: IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses if present
and easy to do – continue rinsing
P304+P340: IF INHALED: Remove victim to fresh air and keep at rest in a position comfortable for breathing
P405: Store locked up

---

Section 3. Composition/information on ingredients.
4-Methoxymethylphenylboronic acid
Ingredient name:
CAS number: 279262-11-2

---

Section 4. First aid measures
Immediately wash skin with copious amounts of water for at least 15 minutes while removing
Skin contact:
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.
Ingestion:

---

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

---

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

---

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Storage: Store in closed vessels.

---

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

---

Section 9. Physical and chemical properties
Not specified
Appearance:
Boiling point: No data
Melting point: No data
Flash point: No data
Density: No data
Molecular formula: C8H11BO3
Molecular weight: 166.0

---

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide.

---

Section 11. Toxicological information
No data.

---

Section 12. Ecological information
No data.

---

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

---

Section 14. Transportation information
Non-harzardous for air and ground transportation.

---

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

制备方法与用途

理化性质

4-甲氧基甲基苯基硼酸是一种苯硼酸类化合物，在常温常压下为白色至类白色的固体，具有较好的化学稳定性。它难溶于水但可溶于常见的有机溶剂，如乙酸乙酯、二氯甲烷和氯仿。

应用

4-甲氧基甲基苯基硼酸的化学反应活性主要集中在其结构中的硼酸单元，在金属钯催化作用下，可以与芳基卤化物或烯基卤化物发生多种交叉偶联反应。这些反应可应用于联苯类生物活性分子的结构改性及制备。此外，该物质在氧化剂的作用下还可以转化为相应的苯酚类衍生物。

反应信息

• 作为反应物：
  描述：

  4-甲氧基甲基苯基硼酸 在 (1,1'-bis(diphenylphosphino)ferrocene)palladium(II) dichloride 、 tetrakis(actonitrile)copper(I) hexafluorophosphate 、 叠氮基三甲基硅烷 、 2-((S)-4-(tert-butyl)-4,5-dihydrooxazol-2-yl)-2-((S)-4-(tert-butyl)oxazolidin-2-ylidene)acetonitrile 、 potassium carbonate 作用下， 以 1,4-二氧六环 、 二氯甲烷 、 水 为溶剂， 反应 11.0h， 生成
  参考文献：
  名称：

  阴离子双恶唑啉配体可实现铜催化的丙烯酰胺的不对称自由基叠氮化

  摘要：

  用于手性烷基叠氮化物的合成的不对称自由基叠氮化仍然是有机合成中的巨大挑战。我们在此报告了由1摩尔％的铜催化剂催化的丙烯酰胺前所未有的高度对映选择性自由基叠氮化。将底物以良好至优异的对映选择性高产率转化为相应的烷基叠氮化物。值得注意的是，对于这种高度对映选择性的自由基叠氮化，采用阴离子氰基-双恶唑啉（CN-Box）配体对于生成单体Cu II叠氮化物而不是二聚Cu II叠氮化物中间体至关重要。

  DOI：

  10.1002/anie.202015083
• 作为产物：
  描述：

  对溴溴苄 在 正丁基锂 、 sodium hydride 作用下， 以 四氢呋喃 、 正己烷 、 甲苯 为溶剂， 反应 0.25h， 生成 4-甲氧基甲基苯基硼酸
  参考文献：
  名称：

  基于硼氧化合物网络的可回收、坚固且具有高度延展性的热固性材料

  摘要：

  传统的热固性材料具有良好的材料特性，但无法再加工且难以回收。小分子环硼氧烷已被证明会发生可逆的交换反应。在本文中，我们采用硼烷作为动态交联来构建一种新型的热固性材料，该材料强度高、延展性高且可回收利用。描述了环硼氧烷网络的合成和动态机械性能。在水中加热后，该材料可以循环回其单体。凭借众多可调变量，我们预计该系统将成为开发一系列新动态材料的平台。

  DOI：

  10.1021/jacs.8b03257

文献信息

• [EN] HETEROCYCLIC COMPOUNDS AND THEIR USE AS RETINOID-RELATED ORPHAN RECEPTOR (ROR) GAMMA-T INHIBITORS<br/>[FR] COMPOSÉS HÉTÉROCYCLIQUES ET LEUR UTILISATION EN TANT QU'INHIBITEURS GAMMA-T DU RÉCEPTEUR ORPHELIN APPARENTÉ AUX RÉCEPTEURS DES RÉTINOÏDES (ROR) )
  申请人：TAKEDA PHARMACEUTICAL

  公开号：WO2016002968A1

  公开（公告）日：2016-01-07

  Provided are heterocyclic compounds having a RORγt inhibitory action represented by the formula (I): wherein each symbol is as defined in the specification, or a salt thereof.

  提供的是具有RORγt抑制作用的杂环化合物，其由公式(I)表示：其中每个符号如说明书中定义，或其盐。
• Visible-Light-Induced Arene C(sp2)–H Lactonization Promoted by DDQ and tert-Butyl Nitrite
  作者：Yiqing Wang、Shengpeng Wang、Bajin Chen、Meichao Li、Xinquan Hu、Baoxiang Hu、Liqun Jin、Nan Sun、Zhenlu Shen

  DOI：10.1055/s-0039-1691537

  日期：2020.2

  photocatalytic aerobic oxidative lactonization of arene C(sp2)–H bonds proceeds in the presence of 2,3-dichloro-5,6-dicyano-1,4-benzoquinone (DDQ) and tert-butyl nitrite (TBN). Under the optimized conditions, a range of 2-arylbenzoic acids is converted into the corresponding benzocoumarin derivatives in moderate to excellent yields. This method is characterized by its atom economy, mild reaction conditions, the

  在 2,3-二氯-5,6-二氰基-1,4-苯醌 (DDQ) 和亚硝酸叔丁酯 (TBN) 存在下，芳烃 C(sp2)-H 键的可见光光催化有氧氧化内酯化反应进行. 在优化的条件下，一系列 2-芳基苯甲酸以中等至极好的收率转化为相应的苯香豆素衍生物。该方法的特点是原子经济、反应条件温和、使用绿色氧化剂和无金属催化。
• ANTI-VIRAL COMPOUNDS, COMPOSITIONS, AND METHODS OF USE
  申请人：Leivers Martin Robert

  公开号：US20090226398A1

  公开（公告）日：2009-09-10

  Disclosed are compounds and compositions of Formula (I), pharmaceutically acceptable salts and solvates thereof, and their preparation and uses for treating viral infections mediated at least in part by a virus in the Flaviviridae family of viruses.

  披露了公式(I)的化合物和组合物、药物可接受的盐和溶剂化物，以及它们的制备和使用，用于治疗至少部分由黄病毒科病毒家族中的病毒介导的病毒感染。
• A general approach to C-Acyl glycosides via palladium/copper Co-catalyzed coupling reaction of glycosyl carbothioates and arylboronic acids
  作者：Li-Na Wang、You-Hong Niu、Qing-Hui Cai、Qin Li、Xin-Shan Ye

  DOI：10.1016/j.tet.2021.131955

  日期：2021.2

  A general and efficient approach to the synthesis of various C-acyl glycosides has been developed via Pd2(dba)3/CuTC co-catalyzed cross-coupling reaction of glycosyl carbothioates with arylboronic acids. The reaction showed a broad substrate scope and 25 examples were exhibited in 61%–97% isolated yields. Furthermore, this reaction was applied to the gram-scale preparation of C-acyl glycosides. The

  通过Pd 2（dba）3 / CuTC共催化的糖基硫代糖基酸酯与芳基硼酸的交叉偶联反应，已经开发了一种合成各种C-酰基糖苷的通用有效方法。该反应显示出较宽的底物范围，其中25个实例的分离产率为61％–97％。此外，该反应被用于克规模的C-酰基糖苷的制备。偶联的产物可以进一步转化为多种生物学上有用的化合物，例如通过合成保护的Sergliflozin-A模拟物。
• Triazolopyridine cannabinoid receptor 1 antagonists
  申请人：Sun Chongqing

  公开号：US20070004772A1

  公开（公告）日：2007-01-04

  The present application describes compounds according to Formula I, pharmaceutical compositions comprising at least one compound according to Formula I and optionally one or more additional therapeutic agents, and methods of treatment using the compounds according to Formula I both alone and in combination with one or more additional therapeutic agents. The compounds have the following general formula: including all prodrugs, solvates, pharmaceutically acceptable salts and stereoisomers, wherein R 1 , R 2 , R 3 , R 4 and R 5 are described herein.

  本申请描述了符合I式的化合物，包括至少一种符合I式的化合物和可选地一种或多种额外的治疗剂的药物组合物，以及使用符合I式的化合物进行治疗的方法，无论是单独使用还是与一种或多种额外的治疗剂结合使用。这些化合物具有以下一般式： 包括所有的前药、溶剂化合物、药用盐和立体异构体，其中R1、R2、R3、R4和R5如本文所述。